Q5102 is a valid 2023 HCPCS Code that could be used to indicate Injection, infliximab, biosimilar, 10 mg for reimbursement purposes.
Q5102 belongs to Medical Care Type of Service and has been in effect since Apr 01, 2018.
Inj., infliximab biosimilar
Q5102 code information
| HCPCS code: | Q5102 |
| Description: | INJECTION, INFLIXIMAB, BIOSIMILAR, 10 MG |
| Effective Date: | Apr 01, 2018 |
| Added Date: | Jul 01, 2016 |
| Termination Date: | HCPCS Q5102 was terminated on Mar 31, 2018 |
| Pricing indicator: | 51 - DRUGS |
| Multi Pricing indicator: | A - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY |
| Coverage code: | D - SPECIAL COVERAGE INSTRUCTIONS APPLY |
| BETOS code: | O1E - OTHER DRUGS |
| Action code: | N - NO MAINTENANCE FOR THIS CODE |
| Type of Service: |
1 - MEDICAL CARE
P - LUMP SUM PURCHASE OF DME, PROSTHETICS, ORTHOTICS
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to Q5102